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Background: Strenous exercise stimulates the hypothalamic-pituitary (HP) axis in
order to ensure homeostasis and promote anabolism. Furthermore, exercise stimulates
a transient increase in the neurotrophin brain-derived neurotrophic factor (BDNF)
suggested to mediate the anxiolytic effects of exercise. Athletes with secondary
functional hypothalamic amenorrhea (FHA) have been reported to have lower BDNF,
and a blunted HP axis response to exercise as athletes with overtraining syndrome.
Aim: The aim of the study was to investigate the hormonal and BDNF responses to a
two-bout maximal exercise protocol with four hours of recovery in between in FHA and
eumenorrheic (EUM) athletes.
Methods: Eumenorrheic (n = 16) and FHA (n = 14) endurance athletes were
recruited from national teams and competitive clubs. Protocols included gynecological
examination; body composition (DXA); 7-day assessment of energy availability; blood
sampling pre and post the two exercises tests.
Results: There were no differences between groups in hormonal responses to the
first exercise bout. After the second exercise bout IGFBP-3 increased more in FHA
compared with EUM athletes (2.1 ± 0.5 vs. 0.6 ± 0.6 µg/L, p = 0.048). There were
non-significant trends toward higher increase in IGF-1 (39.3 ± 4.3 vs. 28.0 ± 4.6 µg/L,
p = 0.074), BDNF (96.5 ± 22.9 vs. 34.4 ± 23.5 µg/L, p = 0.058), GH to cortisol ratio
(0.329 ± 0.010 vs. 0.058 ± 0.010, p = 0.082), and decrease in IGF-1 to IGFBP-3 ratio
(−2.04 ± 1.2 vs. 0.92 ± 1.22, p = 0.081) in athletes with FHA compared with EUM
athletes. Furthermore, there was a non-significant trend toward a higher increase in
prolactin to cortisol ratio in EUM athletes compared with athletes with FHA (0.60 ± 0.15
vs. 0.23± 0.15, p = 0.071). No differences in the hormonal or BDNF responses between
the two exercise bouts as a result of menstrual function were found.
Conclusion: No major differences in the hormonal or BDNF responses between the
two exercise bouts as a result of menstrual function could be detected.
Keywords: amenorrhea, energy availability, overtraining syndrome, female athlete, brain derived neuronal factor
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INTRODUCTION
Exercise stimulates the hypothalamic-pituitary (HP) axis
leading to increased levels of prolactin (Rojas et al., 2012),
adrenocorticotropic hormone (ACTH), cortisol, growth
hormone (GH), insulin-like growth hormone 1 (IGF-1), and
insulin-like growth factor binding protein (IGFBP) in order to
ensure homeostasis and promote anabolism (Mastorakos et al.,
2005). However, a chronic mild hypercortisolism as well as a
decreased HP-adrenal response to exercise has been reported
in highly trained athletes (Mastorakos et al., 2005). A transient
increase in brain-derived neurotrophic factor (BDNF) seems to
be triggered by high intensity exercise. Neurotrophins including
BDNF are involved in central and peripher cellular energy
processes, such as enhanced skeletal muscle lipid oxidation,
and benefits to mood and various cognitive domains as well as
the growth, development, maintenance and function of several
neuronal systems (Rojas et al., 2006; Knaepen et al., 2010; Skriver
et al., 2014; Dinoff et al., 2017).
Low energy availability (LEA) is a common phenomenon in
female athletes (Gibbs et al., 2013), and is the aetiological factor
of Relative Energy deficiency in Sports (RED-S) with multiple
adverse health outcomes. These include, but are not limited to,
reproductive dysfunction, impaired bone health, immunity and
protein synthesis, as well as elevations in cardiovascular risk
factors and potential negative effects on performance (Mountjoy
et al., 2018). LEA can be the result of eating disorders, intentional
restriction in food in order to loose body weight, a misguided
low energy dens diet, or unintentionally due to the lack of
appetite in periods with high training volumes (Burke et al.,
2018). In healthy women, 5 days of clinical LEA (<125 kJ/kg
FFM/day) (Gibbs et al., 2013) have been shown to alter the
HP axis such as a reduction in the pulsatility of gonadotropin
releasing hormone, and luteinizing hormone, with increased
risk of functional hypothalamic amenorrhea (FHA) (Loucks
and Thuma, 2003). Although both clinical and subclinical LEA
(<188 kJ/kg FFM/day) has been reported in female athletes with
FHA (Gibbs et al., 2013; Melin et al., 2015), multiple alterations
in HP axis with lowered fasting IGF-1 and prolactin levels,
and increased cortisol levels have been observed, indicating an
increased catabolic drive compared with eumenorrheic (EUM)
athletes (Laughlin et al., 1998; Gordon, 2010; Warren, 2011;
Melin et al., 2014; Tornberg et al., 2017).
In studies regarding different exercise intensities between
FHA and EUM athletes, FHA athletes seem to have a blunted
catecholamine (Schaal et al., 2011), and prolactin response
(Loucks and Horvath, 1984; De Souza et al., 1991) following high-
intensity exercise while both suppressed (Loucks and Horvath,
1984; De Souza et al., 1991), and increased cortisol response
have been reported (Sanders et al., 2018). LEA and other
stressors are proposed to inhibit proper recovery especially in
periods with large training volumes, with increased risk of
developing overtraining syndrome with long-term symptoms
of fatigue, and decreased physical and cognitive performance
(Meeusen et al., 2010; Cadegiani and Kater, 2017). Overtraining
syndrome has been proposed to be identified by a blunted HP-
axis hormonal response to a two-bout maximal exercise protocol
(Meeusen et al., 2007; Nederhof et al., 2008). Accordingly, the
aim of the present explorative study was to investigate potential
differences in endocrine and BDNF responses to a two-bout
maximal exercise protocol between FHA and EUM endurance
athletes. Our hypothesis was that the athletes with FHA would
have a more blunted endocrine and BDNF response to the second
exercise test compared with the eumenorrheic athletes.
MATERIALS AND METHODS
Most of the protocols and methods used in this study have
previously been described in detail (Melin et al., 2014, 2015;
Tornberg et al., 2017) but, briefly, competitive athletes (18–
38 years) were recruited through the Danish and Swedish
endurance sport federations (middle and long distance running,
orienteering and triathlon), and through local competitive
endurance sports clubs in the Oresund region of Denmark and
Sweden. Permission to undertake the study was provided by
the Data Inspectorate and the Regional Ethical Committees
in both Sweden and Denmark (Nos. 2011/576 and H-4-2011-
096) and endorsed by the Swedish and Danish Confederations
of Sports and Team Denmark. The protocol was registered
at www.clinicaltrials.gov. All testing complied with the 1964
Declaration of Helsinki.
Exclusion criteria included pregnancy, chronic illness,
smoking, use of hormonal contraceptives including local
intrauterine hormone releasing systems 6 weeks prior to
investigation, injuries preventing the athlete from exercise
training ≥2 weeks, or menstrual dysfunctions other than
secondary FHA. Menstruating athletes were examined and all
tests performed in the early follicular phase, on the second to
the fifth day of bleeding to eliminate hormonal fluctuations
during the luteal phase, and thereby limiting the variability
between subjects. All tests were performed on two consecutive
days. The 1st day included the gynecological trans-vaginal
ultrasound examination (Ultrasound Scanner, Class 1 type B,
B-K Medical Ref Type 2202), menstrual anamnesis performed
by a skilled gynecologist, and blood sex hormones, as well
as body composition assessment by a trained technician by
Dual-energyX-ray absorptiometry (DXA) (Hologic Model
Discovery A 2009, QDR series Hologic Inc., Waltham, MA,
United States) in the fasted, rested state, according to standard
operation procedures. The 2nd day included assessment of
aerobic capacity and hormonal response to incremental exercise
tests. Energy intake was assessed by a prospective weighed food
record for 7 consecutive days in the athletes home environment,
simultaneously with exercise energy expenditure assessments by
heart rate monitors and detailed training logs including type,
duration, and intensity of exercise. Subjects were instructed to
maintain their normal food habits, eating patterns and training
regime during this period. Energy expenditure from the 7 days of
training was averaged to determine exercise energy expenditure
for each subject, and used to calculate EA. Individual prediction
equations from measured heart rate and corresponding energy
expenditure during the incremental maximal exercise test in
the laboratory provided the basis for the calculation of exercise
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energy expenditure, using the training log and heart rate
measurement for each training session. Regression lines were
calculated for corresponding values of heart rate and energy
expenditure during the exercise test in the laboratory, and for
the recorded heart rate during all exercise sessions. EA was
calculated by subtracting mean exercise energy expenditure from
the mean energy intake then calculated relative to FFM. In order
not to overestimate exercise energy expenditure and thereby
underestimate EA, exercise energy expenditure was corrected for
the mean total energy expenditure (measured resting metabolic
rate by ventilated hood and non-exercise activity thermogenesis
by accelerometer) without exercise energy expenditure during
the equivalent time period. Athletes retrospectively classified as
having EUM (n = 16) (menstrual cycles of 28 ± 7 days and sex
hormones within the normal range) and FHA (n = 14) (absence
of at least three consecutive menstrual cycles where other causes
than hypothalamic suppression had been ruled out) (Nattiv
et al., 2007) were included in the analysis. Detailed information
regarding gynecological assessment and characterization is to
be found in Melin et al. (2015), Tornberg et al. (2017). Baseline
characteristics regarding the participants age, anthropometrics,
EA, reproductive function, training amounts and oxygen
consumption have previously been published (Melin et al., 2014,
2015; Tornberg et al., 2017).
The Two-Bout Exercise Protocols
Aerobic Performance and Hormonal Response
Two incremental exercise tests (T1 and T2) on a cycle ergometer
were performed with four hours of recovery in between according
the protocol by Meeusen et al. (2010), since this protocol has
been reported to provide a good indication of the normal stress
related HP-axis response in athletes, with a suppressed HP-axis
response to the second exercise bout in athletes with over training
syndrome. The tests were performed at 11.00 a.m. and 3.00 p.m,
two hours after a standardized breakfast and lunch containing
no more than 650 kcal, respectively. The tests were initiated by
cycling for 6 min at 50 W, followed by an increase in workload of
12–14 W per minute until exhaustion, with a cadence of 60 rpm.
An airtight mask covering the mouth and nose was worn in order
to measure breath-by-breath VO2 and VCO2, for determination
of VO2peak (Oxycon Pro 4, Jaeger, Germany).
Blood Analysis
Venus blood was drawn before and as fast as possible after the
exercises test with the athlete still sitting on the cycle ergometer.
All blood samples were first stored at 4◦C and then centrifuged
and seperated. Serum and plasma were allocated into separate
tubes to be stored at −80◦C. All analyses were performed at the
same time in the same badge.
Pre and post both incremental exercise bouts prolactin was
analyzed using ADVIA Centaur Immunoassay (Systems Siemens
Healthcare Diagnostics Products GmbH, Germany) with analytic
sensitivity of 6.4 to 4240 µ IU/mL and intra- inter-assay
coefficient of variation (CV) of 2.0 and 2.3%, respectively.
ACTH levels were detected using a two-site ELISA [(ABNOVA,
ACTH human ELISA kit, CAT. No. KA0916) Abnova Taiwan
Cooperation, Taipei, Taiwan] with analytic sensitivity of 1.5 to
1045 pg/mL and intra-inter assay CV of 3.7 and 6.0%. Cortisol,
GH, IGF-1, and IGFBP-3 were analyzed using Roche Electro
Chemiluminescence Immunoassay (ECLI; Roche Diagnostic,
Bromma, Sweden) with an analytical sensitivity for the cortisol
assay of 0.5 to 1750 nmol/L, for the GH and IGF-1 assay of 0.03
to 50 µg/L, and for the IGFBP-3 assay of 0.08 to 10 µg/L, with an
intra- and interassay CV of 1.3 and 2.1% (cortisol), 3% (GH), 2.0
and 2.5% (IGF-1), and 8% (IGFBP-3). Insulin was analyzed using
Access Ultrasensitive Insulin assay (Beckman Coulter, Bromma,
Sweden) with an analytic sensitivity of 0.03–50µg/L and an assay
CV of 7 and 8%, respectively. BDNF levels were detected using
a sandwich enzyme-linked immunosorbent assay [ChemikineTM
BDNF sandwich ELISA (CAT. No. CYT306)], Millipore A/S,
Hellerup DK, with an analytic sensitivity of 7.8 to 500 pg/mL and
intra-inter assay CV of 3.7 and 8.5 %. All analysis was conducted
in accordance to the manufacturer’s protocol.
Statistics
Participants were divided into two groups by their reproductive
function: EUM or FHA. Baseline characteristics were
summarized using mean ± SD. Hormonal responses were
described by means of linear mixed models with the three-way
interaction between time-test-reproductive function group as
fixed effect and participants as random effects. Changes from
before to post exercise tests within and between groups were
estimated and compared in post hoc t-tests based on the model
fits. No adjustment for multiplicity was applied. Statistical
significance was defined as p < 0.05. All statistical analyses were
performed using R (R Core Team, 2018).
RESULTS
Athletes with FHA had a lower total body mass and fat mass
compared to EUM (Table 1), but no differences in aerobic
capacity or in total or aerobic weekly training time between
the groups were found. Furthermore, athletes with FHA had
lower FFM compared with EUM athletes, despite the latter group
performing less resistance training. Nineteen participants had
subclinical LEA (ten FHA and eight EUM), during the week
of assessment of which six had clinical LEA (three FHA and
three EUM athletes).
Hormonal Levels at Baseline
At baseline only prolactin levels differed between groups, being
lower in athletes with FHA (Table 2).
Endocrine Response to the Incremental
Exercise Tests
There were no differences in the hormonal response to the first
exercise bout between groups (Table 3). However, following the
second bout, IGFBP-3 increased more in FHA compared with
EUM athletes, with a similar trend for IGF-1 and BDNF (Table 4).
There was also a trend toward a higher increase in GH to
cortisol ratio, and decrease in IGF-1 to IGFBP-3 ratio in FHA
athletes compared with EUM athletes. There was furthermore a
trend toward a higher increase in prolactin to cortisol ratio in
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TABLE 1 | Baseline characteristics of participants according to reproductive
function.
EUM (n = 16) FHA (n = 14) p-value
Age (years) 27.6 ± 5.6 26.1 ± 5.6 0.46
Height (cm) 169 ± 5 167 ± 6 0.38
Body mass (kg) 60.2 ± 7.1 55.0 ± 5.8 0.04
BMI (kg/m2) 21.0 ± 2.0 19.6 ± 1.8 0.05
Fat mass (kg) 12.8 ± 3.2 10.1 ± 2.6 0.02
Fat mass (%) 20.9 ± 3.5 18.3 ± 3.1 0.04
FFM (kg) 47.8 ± 4.8 44.9 ± 4.0 0.08
FFM (%) 79.1 ± 3.5 81.8 ± 3.2 0.04
Energy availability (kJ/kg FFM) 163 ± 13 171 ± 15 0.68
VO2peak (L/min) 3.19 ± 0.38 3.13 ± 0.44 0.67
Exercise (min/week) 661 ± 240 721 ± 300 0.59
Aerobic exercise (min/week) 566 ± 312 429 ± 326 0.25
Resistance training (min/week) 49 ± 54 128 ± 112 0.02
Data shown as mean ± SD. EUM, eumenorrheic athletes; FHA, functional
hypothalamic amenorrhoeic athletes; BMI, body mass index; FFM, fat free mass.
TABLE 2 | Baseline hormonal levels according to reproductive function.
EUM (n = 16) FHA (n = 14) p-value
ACTH (µg/L) 18.7 ± 9.9 21.9 ± 7.8 0.35
Cortisol (nmol/L) 342 ± 119 375 ± 69 0.38
GH (µg/L) 0.71 ± 0.32 2.2 ± 3.7 0.15
IGF-1 (µg/L) 231 ± 51 219 ± 58 0.55
IGFBP-3 (µg/L) 5.4 ± 0.6 5.4 ± 1.6 0.95
Insulin (pmol/L) 107 ± 38 118 ± 68 0.60
Glucose (nmol/L) 4.8 ± 0.7 4.3 ± 0.9 0.60
Prolactin (µg/L) 231 ± 90 145 ± 28 <0.01
BDNF (µg/L) 113.7 ± 90.1 82.5 ± 64.3 0.30
Data shown as mean ± SD. ACTH, adrenocorticotropic hormone; BDNF, brain-
derived neurotrophic factor; cortisol, GH, growth hormone; IGF-1, insulin-like
growth factor 1; IGFBP3, insulin-like growth factor-binding protein 3 in athletes
with EUM, eumenorrhea; FHA, functional hypothalamic amenorrhea.
EUM compared with FHA athletes. There were no differences in
the hormonal responses between Test1 and Test2 as a result of
menstrual function (Table 5).
DISCUSSION
This explorative study investigated the differences in hormonal
and BDNF responses to strenuous exercise in FHA and
EUM endurance athletes. In this cohort of intensive training
women with either FHA or EUM, current subclinical LEA
was found in 93 and 75%, respectively. Athletes with FHA
were characterized by lower total body mass, lower absolute
fat mass and FFM. Athletes with FHA and EUM trained
equally regarding aerobic exercise, but EUM performed less
resistant training.
The main finding was that there were no major differences
in the hormonal responses between the two exercise bouts as
a result of menstrual function. Thus, no signs of overtraining
syndrome in the form of blunted hormonal responses after a
second bout of exercise were found in these women, regardless
of menstrual status.
Catecholamines increases the cardiac output and blood flow
to the muscles, and cortisol with its principal regulator ACTH is
secreted by the adrenal cortex to increase blood glucose levels to
support the nutrient requirements of the central nervous system
during stress, such as prolonged exercise, starvation, and hepatic
glycogen depletion (Schaal et al., 2011; Elnour, 2018). Long-time
exposure to stress hormones is also associated with increased
proteolysis (Darmaun et al., 1988). Elevated fasting cortisol levels
have earlier been reported in this group of athletes with FHA
compared with EUM athletes (Melin et al., 2015), potentially
explaining the lower FFM in athletes with FHA despite more
resistance training compared with EUM athletes. However, two
hours after a standardized breakfast (at 11 a.m.) we found no
differences in non-fasting cortisol levels between the groups,
which is in line with earlier findings reporting similar cortisol
levels between athletes with FHA and EUM (De Souza et al., 1991;
Schaal et al., 2011). In the present study we found no differences
in the exercise induced cortisol responses between FHA and
EUM in contrast to studies reporting blunted catecholamine
(norepinephrine and epinephrine) and cortisol responses to a
sub maximal exercise test in athletes with FHA compared with
EUM athletes (Loucks and Horvath, 1984; De Souza et al., 1991;
Schaal et al., 2011).
Growth hormone is essential for muscle growth mediated
by IGF-1, and lowered IGF-1 levels are strongly associated
with energy deficiency and has been reported in male cyclists
after an ultra-endurance event (Geesmann et al., 2017), and in
adolescent male wrestlers during a competitive wrestling season
(Roemmich and Sinning, 1997). Increased GH secretion has also
been reported in female athletes compared with non-athletes
(Laughlin and Yen, 1996), and in patients with anorexia nervosa
with systemic low IGF-1 levels, indicating a hepatic GH resistance
(Roemmich and Sinning, 1997; Misra and Klibanski, 2014).
Although similar IGF-1 levels have been reported in FHA and
EUM athletes and non-athletes, higher IGFBP levels, and thereby
a lower IGF-1 to IGFBP ratio have been reported in FHA athletes
which has been suggested to act as an energy-conserving strategy
by minimizing the hypoglycemic action of IGF-I (Laughlin and
Yen, 1996). In the present study we found no difference in the
exercise induced response in either GH, IGF-1 levels or GH to
cortisol and GH to insulin ration between groups. However, the
tendency toward an increased IGF-1 to cortisol ration in EUM
athletes compared with FHA athletes after the second exercise
bout might indicate a more anabolic response in EUM athletes,
while the increased IGFBP-3 levels in FHA athletes compared
with EUM athletes might indicate a more catabolic response
to strenuous exercise in FHA athletes. Therefore, more studies
investigating potential differences in anabolic response to exercise
between EUM and FHA athletes are needed.
Prolactin is a sex hormone involved in diverse physiological
processes, including angiogenesis, immune response,
osmoregulation, and brain functions such as cognition and
memory as well as having neuroprotective functions (Cabrera-
Reyes et al., 2017). In the present study, baseline prolactin
levels were lower in FHA compared with EUM athletes,
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TABLE 3 | Comparison of changes in hormonal responses from pre to post Test1, within and between reproductive function groups.
Test1: change from pre to post within and between groups
Within groups Between groups
EUM (n = 16) FHA (n = 14)
p-Value p-Value p-Value
Prolactin (µg/L) 68.6 ± 34.1 0.044 108.2 ± 35.7 0.002 −39.7 ± 49.1 0.419
ACTH (µg/L) 65.9 ± 12.4 <0.001 68.7 ± 12.5 <0.001 2.8 ± 17.6 0.874
Cortisol (nmol/L) 7.6 ± 37.5 0.838 79.5 ± 38.9 0.041 −71.8 ± 53.9 0.183
GH (µg/L) 3.7 ± 2.1 0.077 4.1 ± 2.1 0.049 −0.4 ± 2.9 0.881
IGF-1 (µg/L) 32.8 ± 4.3 <0.001 36.5 ± 4.3 <0.001 −3.7 ± 6.1 0.545
IGFBP-3 (µg/L) 0.9 ± 0.5 0.090 0.7 ± 0.5 0.218 0.2 ± 0.8 0.743
Insulin (pmol/L) −58.3 ± 14.2 <0.001 −62.5 ± 14.2 <0.001 4.2 ± 20.0 0.833
Prolactin:cortisol 0.27 ± 0.15 0.061 0.16 ± 0.152 0.278 01.1 ± 0.21 0.605
Cortisol:insulin 0.007 ± 0.003 0.011 0.009 ± 0.003 0.001 −0.002 ± 0.004 0.605
GH:cortisol 0.010 ± 0.010 0.338 0.003 ± 0.01 0.757 0.006 ± 0.014 0.659
GH:insulin 0.852 ± 1.39 0.540 0.985 ± 1.39 0.479 −0.133 ± 1.966 0.946
IGF-1:IGFBP-3 −0.88 ± 1.17 0.452 0.11 ± 1.17 0.922 −0.99 ± 1.65 0.548
IGF:cortisol 0.187 ± 0.093 0.045 0.014 ± 0.097 0.884 0.173 ± 0.134 0.198
BDNF (µg/L) 3.6 ± 22.9 0.875 41.9 ± 23.5 0.074 −38.3 ± 32.8 0.243
Data shown as mean and standard error. EUM, eumenorrheic athletes; athletes with FHA, functional hypothalamic amenorrhea; ACTH, adrenocorticotropic hormone;
BDNF, brain derived neurotrophic factor; GH, growth hormone; IGF-1, insulin like growth factor 1; IGFBP-3, insulin like growth factor binding protein 3.
TABLE 4 | Comparison of changes in hormonal responses from pre to post Test2, within and between reproductive function groups.
Test2: change from pre to post within and between groups
Within group Between groups
EUM (n = 16) FHA (n = 14)
p-Value p-Value p-Value
Prolactin (µg/L) 176.9 ± 34.1 <0.001 148.4 ± 34.1 <0.001 28.5 ± 48.2 0.554
ACTH (µg/L) 67.2 ± 12.1 <0.001 65.1 ± 12.5 <0.001 −2.1 ± 17.4 0.902
Cortisol (nmol/L) 53.8 ± 37.5 0.151 98.6 ± 37.5 0.008 −44.9 ± 53.0 0.397
GH (µg/L) 15.7 ± 2.2 <0.001 12.9 ± 2.1 <0.001 2.8 ± 3.0 0.355
IGF-1 (µg/L) 28.0 ± 4.6 <0.001 39.3 ± 4.3 <0.001 −11.3 ± 6.3 0.074
IGFBP-3 (µg/L) 0.6 ± 0.6 0.321 2.1 ± 0.5 <0.001 −1.5 ± 0.8 0.048
Insulin (pmol/L) 6.2 ± 14.8 0.675 13.7 ± 14.2 0.332 −7.5 ± 20.5 0.712
Prolactin:cortisol 0.60 ± 0.15 <0.001 0.23 ± 0.15 0.116 0.37 ± 0.21 0.071
Cortisol:insulin 0.004 ± 0.003 0.202 0.008 ± 0.003 0.005 −0.004 ± 0.004 0.310
GH:cortisol 0.058 ± 0.010 <0.001 0.329 ± 0.010 0.001 0.025 ± 0.014 0.082
GH:insulin 5.318 ± 1.450 <0.001 4.376 ± 1.391 0.002 0.942 ± 2.008 0.639
IGF-1:IGFBP-3 0.92 ± 1.22 0.454 −2.04 ± 1.2 0.080 2.96 ± 1.70 0.081
IGF:cortisol 0.001 ± 0.098 0.991 −0.051 ± 0.093 0.585 0.052 ± 0.135 0.700
BDNF (µg/L) 34.4 ± 23.5 0.143 96.5 ± 22.9 <0.001 −62.1 ± 32.8 0.058
Data shown as mean and standard error. EUM, Eumenorrheic athletes; athletes with FHA, functional hypothalamic amenorrhea; ACTH, adrenocorticotropic hormone;
BDNF, brain derived neurotrophic factor; GH, growth hormone; IGF-1, insulin like growth factor 1; IGFBP-3, insulin like growth factor binding protein 3.
but no differences in the exercise induced response between
FHA and EUM athletes were found which is in contrast
to the findings of De Souza et al. who reported a blunted
prolactin response to exercise in FHA compared with EUM
athletes (Loucks and Horvath, 1984; De Souza et al., 1991).
However, we did find a more pronounced exercise induced
increase in the prolactin to cortisol ratio in EUM athletes
compared with athletes with FHA, indicating a more profound
anabolic response.
Brain-derived neurotrophic factor is an essential neurotrophin
connected with central and peripheral molecular processes of
energy metabolism and homeostasis (Knaepen et al., 2010).
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TABLE 5 | Comparison of hormonal responses between Test1 and Test2, within and between reproductive function groups.
Difference in change from pre to post between Test1 and Test2
Within groups
EUM (n = 16) FHA (n = 14) Between groups
p-Value p-Value p-Value
Prolactin (µg/L) 108.4 ± 48.2 0.025 40.2 ± 49.1 0.413 68.2 ± 68.8 0.322
ACTH (µg/L) 1.33 ± 17.3 0.939 −3.61 ± 7.7 0.839 4.94 ± 24.8 0.842
Cortisol (nmol/L) 46.1 ± 55.0 0.384 19.2 ± 54.0 0.722 27.0 ± 75.6 0.721
GH (µg/L) 12.0 ± 3.0 0.003 8.8 ± 2.9 <0.001 3.2 ± 4.2 0.447
IGF-1 (µg/L) −4.8 ± 6.3 0.451 2.8 ± 6.1 0.650 −7.5 ± 8.8 0.391
IGFBP-3 (µg/L) −0.3 ± 0.8 0.652 1.4 ± 0.8 0.058 −1.8 ± 1.1 0.100
Insulin (pmol/L) 64.5 ± 20.5 0.002 76.2 ± 20.0 <0.001 −11.8 ± 28.6 0.681
Prolactin:cortisol 0.33 ± 0.21 0.111 0.06 ± 0.21 0.758 0.26 ± 0.29 0.370
Cortisol:insulin −0.003 ± 0.004 0.401 −0.001 ± 0.004 0.734 −0.002 ± 0.006 0.723
GH:cortisol 0.048 ± 0.014 <0.001 0.030 ± 0.014 0.039 0.019 ± 0.204 0.358
GH:insulin 4.466 ± 0.262 0.026 3.391 ± 1.967 0.085 1.074 ± 2.811 0.702
IGF-1:IGFBP-3 1.80 ± 1.70 0.289 −2.16 ± 1.65 0.192 3.95 ± 2.37 0.095
IGF:cortisol −0.186 ± 0.135 0.170 −0.065 ± 0.134 0.629 −0.121 ± 0.190 0.527
BDNF (µg/L) 30.8 ± 32.8 0.348 54.6 ± 32.8 0.096 −23.8 ± 46.4 0.608
Data shown as mean and standard error. EUM, Eumenorrheic athletes; athletes with FHA, functional hypothalamic amenorrhea; ACTH, adrenocorticotropic hormone;
BDNF, brain derived neurotrophic factor; GH, growth hormone; IGF-1, insulin like growth factor 1; IGFBP-3, insulin like growth factor binding protein 3.
A transient increase in BDNF triggered by high intensity
exercise has been reported (Knaepen et al., 2010), and is
suggested to mediate the beneficial antidepressant and anxiolytic
effects of exercise (Antunes et al., 2016), and is positively
correlated with cognitive performance (Heijnen et al., 2015).
Lower fasting concentration of BDNF has earlier been reported
in women with FHA compared with EUM women assessed
in the follicular phase between the 8th and 12th day of the
cycle (Podfigurna-Stopa et al., 2013). The exercise induced
BDNF increase is reported to be affected by various factors
such as exercise regimen and hormonal changes during the
menstrual cycle, with a decrease in BDNF release during the
luteal phase and increase during the follicular phase (Heijnen
et al., 2015). In the present study, however, no differences
in baseline BDNF levels were found between FHA and EUM
athletes assessed in the early follicular phase (2nd to 5th day
of bleeding), and exercise induced increase was only seen
in FHA athletes.
Limitations
The strength of this study is the thorough gynecological
characterization, and that standardized protocols were
followed in all examinations and tests. However, the lack of
continuous assessment of ovulation in eumenorrheic subjects
is a limitation since subclinical menstrual dysfunction due to
LEA cannot be ruled out, especially since current subclinical
and clinical LEA was equally prevalent in eumenorrheic
and FHA participants. A further limitation is the low
number of participants, which means a potential lack of
ability to detect differences among the many secondary
outcomes for which no prior sample size calculation
was carried out. Moreover, the high number of variables
assessed and statistically tested in the present study also
increases the risk of type 1 errors. Thus the reported
findings should mostly be viewed as exploratory and
hypothesis generating.
CONCLUSION
No major differences in the hormonal or BDNF responses
between the two exercise bouts as a result of menstrual function
were found in this study.
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